These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28763342)

  • 1. Apparent resistant hypertension and the risk of vascular events and mortality in patients with manifest vascular disease.
    van der Sande NGC; de Beus E; Bots ML; Voskuil M; Blankestijn PJ; Visseren F; Spiering W;
    J Hypertens; 2018 Jan; 36(1):143-150. PubMed ID: 28763342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease.
    de Beus E; Bots ML; van Zuilen AD; Wetzels JF; Blankestijn PJ;
    Hypertension; 2015 Nov; 66(5):998-1005. PubMed ID: 26351024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to antihypertensive treatment and long-term risk: The Atherosclerosis Risk in Communities study.
    Wijkman MO; Malachias MVB; Claggett BL; Cheng S; Matsushita K; Shah AM; Jhund PS; Coresh J; Solomon SD; Vardeny O
    J Clin Hypertens (Greenwich); 2021 Oct; 23(10):1887-1896. PubMed ID: 34547175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resistant hypertension and the risk of major adverse cardiac and cerebrovascular events in outpatients].
    Xia JH; Wang XY; Kang YY; Huang JF; Guo QH; Cheng YB; Li Y; Wang JG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Aug; 52(8):884-891. PubMed ID: 39143779
    [No Abstract]   [Full Text] [Related]  

  • 6. Mortality Risk Associated With Resistant Hypertension Among Women: Analysis from Three Prospective Cohorts Encompassing the Spectrum of Women's Heart Disease.
    Smith SM; Huo T; Gong Y; Handberg E; Gulati M; Merz CN; Pepine CJ; Cooper-DeHoff RM
    J Womens Health (Larchmt); 2016 Oct; 25(10):996-1003. PubMed ID: 27224417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory Hypertension and Risks of Adverse Cardiovascular Events and Mortality in Patients With Resistant Hypertension: A Prospective Cohort Study.
    Cardoso CRL; Salles GF
    J Am Heart Assoc; 2020 Sep; 9(17):e017634. PubMed ID: 32851922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent treatment-resistant hypertension associated lifetime cardiovascular risk in a longitudinal national registry.
    Ebinger JE; Kauko A; ; Bello NA; Cheng S; Niiranen T
    Eur J Prev Cardiol; 2023 Aug; 30(10):960-968. PubMed ID: 36866422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent treatment resistant hypertension and the risk of recurrent cardiovascular events and mortality in patients with established vascular disease.
    Groenland EH; Bots ML; Asselbergs FW; de Borst GJ; Kappelle LJ; Visseren FLJ; Spiering W;
    Int J Cardiol; 2021 Jul; 334():135-141. PubMed ID: 33932429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.
    Zanchetti A; Hansson L; Dahlöf B; Elmfeldt D; Kjeldsen S; Kolloch R; Larochelle P; McInnes GT; Mallion JM; Ruilope L; Wedel H
    J Hypertens; 2001 Jun; 19(6):1149-59. PubMed ID: 11403365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.
    Bangalore S; Fayyad R; Laskey R; Demicco DA; Deedwania P; Kostis JB; Messerli FH;
    Am J Med; 2014 Jan; 127(1):71-81.e1. PubMed ID: 24210549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular morbidity of severe resistant hypertension among treated uncontrolled hypertensives: a 4-year follow-up study.
    Kasiakogias A; Tsioufis C; Dimitriadis K; Konstantinidis D; Koumelli A; Leontsinis I; Andrikou E; Vogiatzakis N; Marinaki S; Petras D; Fragoulis C; Konstantinou K; Papademetriou V; Tousoulis D
    J Hum Hypertens; 2018 Jul; 32(7):487-493. PubMed ID: 29713047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of lower achieved blood pressure on outcomes in hypertensive patients.
    Okin PM; Hille DA; Kjeldsen SE; Dahlöf B; Devereux RB
    J Hypertens; 2012 Apr; 30(4):802-10; discussion 810. PubMed ID: 22343536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Individuals With Apparent Resistant Hypertension Using Contemporary Guidelines: Insights From CV-QUIC.
    Ebinger JE; Gluckman TJ; Magraner J; Chiu ST; Rider D; Thomas C; Das SR; Ho PM; Shreenivas S; Bradley S
    Hypertension; 2023 Sep; 80(9):1845-1855. PubMed ID: 37357771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis.
    Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Crowley K; Goto S; Ohman EM; Bakris GL; Perlstein TS; Kinlay S; Bhatt DL;
    Eur Heart J; 2013 Apr; 34(16):1204-14. PubMed ID: 23144048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.
    Irvin MR; Booth JN; Shimbo D; Lackland DT; Oparil S; Howard G; Safford MM; Muntner P; Calhoun DA
    J Am Soc Hypertens; 2014 Jun; 8(6):405-13. PubMed ID: 24952653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study.
    Boman K; Gerdts E; Wachtell K; Dahlöf B; Nieminen MS; Olofsson M; Papademetriou V; Devereux RB
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):242-8. PubMed ID: 19369828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.